Insider Shareholders with Direct Ownership of Rocket Pharmaceuticals, Inc. (RCKT)
This section provides a comprehensive overview of the insiders with direct ownership of Rocket Pharmaceuticals, Inc. (RCKT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
ROCKET PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Gaurav Shah
CEO |
371,457 | 345,996 | 772,680 $7.3 Million | 22 |
Feb 21, 2025
Reduced 2.07%
|
| 335,929 | 45,458 | 444,103 $4.2 Million | 19 |
Feb 21, 2025
Reduced 1.35%
|
|
| 304,847 | 63,650 | 237,638 $2.25 Million | 8 |
Feb 25, 2025
Reduced 2.68%
|
|
|
Martin Wilson
General Counsel |
155,132 | 23,860 | 150,696 $1.42 Million | 12 |
Feb 21, 2025
Reduced 2.09%
|
|
Aaron Ondrey
Chief Financial Officer |
137,139 | 0 | 137,139 $1.3 Million | 2 |
Feb 11, 2025
Added 39.72%
|
| 99,624 | 193,124 | 114,784 $1.08 Million | 5 |
Apr 15, 2024
Reduced 8.01%
|
|
| 87,758 | 18,638 | 69,140 $653,373 | 5 |
Oct 31, 2024
Reduced 4.26%
|
|
| 92,599 | 31,180 | 65,757 $621,403 | 32 |
Feb 21, 2025
Reduced 4.0%
|